BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5309028)

  • 1. [Treatment of the tourniquet syndrome with Trasylol].
    Kristen H; Eigler FW; Stock W
    Langenbecks Arch Chir; 1969; 325():292-5. PubMed ID: 5309028
    [No Abstract]   [Full Text] [Related]  

  • 2. [The proteinase inhibitor trasylol as therapeutic principle in the tourniquet syndrome].
    Eigler FW; Kristen H; Stock W; Höfer I
    Bull Soc Int Chir; 1970; 29(4):197-203. PubMed ID: 5312417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of a protease inhibitor on the Tourniquet syndrome in the rat. II. Improvement of survival time in Tourniquet-shock by Trasylol].
    Stock W; Eigler FW
    Z Gesamte Exp Med Einschl Exp Chir; 1969 Sep; 151(1):64-73. PubMed ID: 5308803
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pathophysiology of tourniquet shock].
    Rahmer H
    Fortschr Med; 1979 Aug; 97(29):1277-9. PubMed ID: 313360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Field study on the therapeutic value of trasylol in traumatic shock].
    Schneider B; Schnells G; Trentz O; Tscherne H
    Chirurg; 1976 Apr; 47(4):185-8. PubMed ID: 1085692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trasylol R on the status of experimental shock (preliminary results)].
    Back N; Wilkens H; Munson AE; Steger R
    Rev Bras Med; 1968 Jun; 25(6):410-5. PubMed ID: 5304846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a field study on the therapeutic value of aprotinin in traumatic shock (author's transl)].
    Schneider B
    Arzneimittelforschung; 1976; 26(8):1606-10. PubMed ID: 795437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trasylol in the shock therapy. Its effects and their interpretation].
    Haberland GL; Koslowski L; Matis P
    Med Welt; 1972 Aug; 23(31):1049-56. PubMed ID: 4539608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a protease inhibitor on the Tourniquet syndrome in the rat. I. Influence on the postischemic edema in relation to dose and time of Trasylol injection].
    Eigler FW; Stock W; Höfer I
    Z Gesamte Exp Med Einschl Exp Chir; 1969 Sep; 151(1):55-63. PubMed ID: 5308802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic responses after volume replacement and proteinase inhibition in canine tourniquet shock].
    Brückner UB; Opherk D; Schmier J
    Arztl Forsch; 1972 Jan; 26(1):17-25. PubMed ID: 4536809
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE EFFECT OF DEXAMETHASONE IN TOURNIQUET SHOCK].
    SATORI O; SZABO G
    Z Gesamte Exp Med; 1963 Jun; 137():47-51. PubMed ID: 14050543
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phlogodym on tourniquet shock.
    Lázár G; Karády S; Husztik E
    Thromb Diath Haemorrh; 1969 Feb; 21(1):159-65. PubMed ID: 4886540
    [No Abstract]   [Full Text] [Related]  

  • 13. GUANETHIDINE ON BLOOD PRESSURE AND SURVIVAL OF RATS AFTER TOURNIQUET SHOCK.
    DAVANZO JP; WEEKS JR
    Arch Int Pharmacodyn Ther; 1964 Aug; 150():447-50. PubMed ID: 14203122
    [No Abstract]   [Full Text] [Related]  

  • 14. Generation, in activation and level of blood kinins during tourniquet shock in rabbits.
    Pałgan E
    Acta Physiol Pol; 1981; 32(1):37-46. PubMed ID: 6264737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The tourniquet-syndrome--a severe complication after embolectomy of saddle embolism (author's transl)].
    Stock W; Geppert E; Zehle A
    Thoraxchir Vask Chir; 1975 Aug; 23(4):324-9. PubMed ID: 1084027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tourniquet-schock following treatment with streptase, prednisolone and trasylol. Pathologic-anatomic findings].
    Schubert GE; Durst J; Rahmer H
    Med Welt; 1977 Jul; 28(27):1190-4. PubMed ID: 301980
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of proteolytic enzyme inhibitors on traumatic swelling.
    Rosenthal SM
    J Trauma; 1973 Jun; 13(6):548-53. PubMed ID: 4541223
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oxygen consumption and oxygen deficit in tourniquet shock in dogs].
    Brückner UB; Herrmann H; Schmier J; Ulmer HE
    Z Kreislaufforsch; 1971 Jun; 60(6):545-56. PubMed ID: 5558948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the proteinase inhibitor (aprotinin) on the course of experimental burn shock].
    Rybák M; Petz R; Jańecek J; Petáková M
    Cas Lek Cesk; 1976 Sep; 115(35):1067-71. PubMed ID: 1086136
    [No Abstract]   [Full Text] [Related]  

  • 20. Bradykinin, kinin-forming and kininase activities of plasma and tourniquet shock in dogs.
    Tokita T
    Sapporo Igaku Zasshi; 1968; 33(4):214-26. PubMed ID: 5750816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.